- Home
- CVRX vs PLCE Comparison
CVRX vs PLCE Comparison
Compare CVRX & PLCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVRX
- PLCE
- Stock Information
- Founded
- CVRX 2000
- PLCE 1969
- Country
- CVRX United States
- PLCE United States
- Employees
- CVRX N/A
- PLCE N/A
- Industry
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- PLCE Clothing/Shoe/Accessory Stores
- Sector
- CVRX Health Care
- PLCE Consumer Discretionary
- Exchange
- CVRX Nasdaq
- PLCE Nasdaq
- Market Cap
- CVRX 203.9M
- PLCE 169.6M
- IPO Year
- CVRX 2021
- PLCE 1997
- Fundamental
- Price
- CVRX $9.11
- PLCE $7.14
- Analyst Decision
- CVRX Buy
- PLCE Hold
- Analyst Count
- CVRX 7
- PLCE 1
- Target Price
- CVRX $14.00
- PLCE $7.00
- AVG Volume (30 Days)
- CVRX 202.9K
- PLCE 663.1K
- Earning Date
- CVRX 10-28-2025
- PLCE 09-05-2025
- Dividend Yield
- CVRX N/A
- PLCE N/A
- EPS Growth
- CVRX N/A
- PLCE N/A
- EPS
- CVRX N/A
- PLCE N/A
- Revenue
- CVRX $54,652,000.00
- PLCE $1,338,867,000.00
- Revenue This Year
- CVRX $11.32
- PLCE N/A
- Revenue Next Year
- CVRX $18.58
- PLCE $0.68
- P/E Ratio
- CVRX N/A
- PLCE N/A
- Revenue Growth
- CVRX 23.11
- PLCE N/A
- 52 Week Low
- CVRX $4.30
- PLCE $3.66
- 52 Week High
- CVRX $18.55
- PLCE $17.19
- Technical
- Relative Strength Index (RSI)
- CVRX 66.69
- PLCE 65.30
- Support Level
- CVRX $8.56
- PLCE $6.18
- Resistance Level
- CVRX $8.94
- PLCE $7.80
- Average True Range (ATR)
- CVRX 0.41
- PLCE 0.53
- MACD
- CVRX 0.14
- PLCE 0.04
- Stochastic Oscillator
- CVRX 91.84
- PLCE 90.17
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
About PLCE Children's Place Inc. (The)
Children's Place Inc operate an omni-channel children's specialty portfolio of brands in North America. It designs, contract to manufacture, and sell fashionable, high-quality apparel, accessories and footwear predominantly at value prices under proprietary The Children's Place, Place, Baby Place, Gymboree, Sugar & Jade, and PJ Place brand names. The Company classifies its business into two segments: The Children's Place U.S. and The Children's Place International.